Mass Torts News

THE OTHER PFAS CASES

MILLIONS OF PFAS REMEDATION CASES WAITING TO BE SIGNED

TAKE CONTROL OF YOUR FIRMS PFAS LITIGATION DESTINY

PFAS LITIGATION WILL SOAR IN LATE 2024

PFAS, Litigation Update, Water Source Clients

Thousands of Consumer Class Actions Waiting on Your Firm

Will one or more of the PFAS Defendants File Bankruptcy

THERE ARE P.I. LAWERS THAT PAY ATTENTION AND THOSE WHO DON’T GET PAID

Over the past month, nearly every maker of SSRI and similar antidepressant drugs have added extensive warnings to their labels.

GET UP TO SPEED ON PFAS OR GET LEFT BEHIND

Embrace the Future: How Google's AI Will Revolutionize Legal Search Marketing

You Didn’t Tell Us About the PFAS in That Product!

In this two-part video series (15 minutes) I talk about the various emerging PFAS litigations and why your firm should be paying attention.  Major cases may walk through your door or otherwise “fall in your lap”. You need to be up to speed on all things “PFAS” so you don’t miss major cases that may literally walk through your door. 

Will Your Case Become the Next Block Buster Movie?

Should your Firm Retain ERC Client

PFAS, Litigation Update, Camp Lejeune

PLAINTIFF FIRMS - IT IS TIME TO GET UP TO SPEED ON ALL THINGS PFAS, NOW, RIGHT NOW!

THE 3M EAR PLUG APPEAL RULING WILL NOT NECESSARILY END ANYTHING

There is no valid reason that your single event personal injury firm should not also be involved in mass personal injury litigation! You control the level of risk you take in Mass Torts, you can and should walk before you run. There is no need to unduly risk the ongoing success of your current practice to achieve the growth offered in Mass Torts.

If you had a time machine, would you travel back to the late 1980s and learn all that you could about the emerging asbestos litigation? 

Before you decide to take a pass on this important litigation, believing there aren’t that many cases to be filed, attend our Mass Tort Success Course in June. You may change your mind when you understand the facts. 

In our upcoming June 2023 Mass Tort Success Course, we will compare the Taxotere Hair Loss litigation with the more recent Taxotere Canalicular Stenosis litigation. 

This litigation is past the emerging phase, however, there are still clients in need of representation. We are going to cover this drug and the ongoing litigation.

The emerging litigation involving the drug Tepezza, will likely be consolidated (MDL) within the next few months. The formation of an MDL generally causes firms to take note and consider becoming involved in the given mass litigation.